Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway - Summary - MDSpire
Advertisement
Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway
To analyze the regulatory framework for CuO and Cu2O nanoparticles in the EU and assess their potential health hazards and biological interactions.
Approach:
Regulatory Analysis: Examine existing EU regulations regarding copper and its oxide nanoparticles, focusing on their definitions and implications for risk assessment.
Scientific Review: Conduct a bibliometric and systematic review of scientific literature on the biological interactions and toxicity of CuO and Cu2O nanoparticles.
Mechanistic Insights: Investigate the mechanisms of absorption, biodistribution, and cell death pathways related to CuO and Cu2O nanoparticles.
Key Findings:
EU regulations do not consistently differentiate between nanoforms and non-nanoforms of copper.
CuO and Cu2O nanoparticles may traverse the intestinal barrier and accumulate in vulnerable tissues.
CuO and Cu2O nanoparticles can initiate unique biological responses, including cuproptosis.
Interpretation:
The review highlights regulatory deficiencies and the need for more scientific data on the risks associated with CuO and Cu2O nanoparticles.
Limitations:
Existing regulatory frameworks may not adequately address the unique properties of nanoparticles.
There is a lack of uniform definitions for nanomaterials across different EU regulations.
Conclusion:
The review emphasizes the importance of addressing knowledge gaps in the risk evaluation and regulation of CuO and Cu2O nanoparticles.
by Sophie Scholz, Julia Prinz, Linde Sevenants, Andrea Holzwarth, Birgit Mertens, Robert Pieper, Vera Ritz, Kirsten Schulz, Holger Sieg, Aswin Mangerich, Linda Böhmert
